Docetaxel and Capecitabine in Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

December 31, 2007

Conditions

Stomach NeoplasmNeoplasm Metastasis

Interventions

DRUG

Docetaxel

DRUG

Capecitabine

Trial Locations (1)

Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Dept. of Hematology and Oncology, Berlin

All Listed Sponsors

lead

Charite University, Berlin, Germany

OTHER

NCT00142038 - Docetaxel and Capecitabine in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter